The invention relates to novel sulfonamides of general formula (I)
##STR00001## where the substituents R.sup.1, R.sup.2, R.sup.3, R.sup.4,
A and X have the given meanings, pharmaceutical compositions containing
them, and a method of using them as antiviral agents, in particular
against cytomegaloviruses.